BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 9013769)

  • 1. The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription.
    Masuyama H; Jefcoat SC; MacDonald PN
    Mol Endocrinol; 1997 Feb; 11(2):218-28. PubMed ID: 9013769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB.
    Jurutka PW; Remus LS; Whitfield GK; Thompson PD; Hsieh JC; Zitzer H; Tavakkoli P; Galligan MA; Dang HT; Haussler CA; Haussler MR
    Mol Endocrinol; 2000 Mar; 14(3):401-20. PubMed ID: 10707958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vitamin D receptor interacts with general transcription factor IIB.
    MacDonald PN; Sherman DR; Dowd DR; Jefcoat SC; DeLisle RK
    J Biol Chem; 1995 Mar; 270(9):4748-52. PubMed ID: 7876247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription.
    Blanco JC; Wang IM; Tsai SY; Tsai MJ; O'Malley BW; Jurutka PW; Haussler MR; Ozato K
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1535-9. PubMed ID: 7878015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: relief of repression by CREB-binding protein.
    Raval-Pandya M; Dhawan P; Barletta F; Christakos S
    Mol Endocrinol; 2001 Jun; 15(6):1035-46. PubMed ID: 11376120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction.
    Masuyama H; Brownfield CM; St-Arnaud R; MacDonald PN
    Mol Endocrinol; 1997 Sep; 11(10):1507-17. PubMed ID: 9280066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the 1,25-dihydroxyvitamin D3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro.
    Jurutka PW; Hsieh JC; Remus LS; Whitfield GK; Thompson PD; Haussler CA; Blanco JC; Ozato K; Haussler MR
    J Biol Chem; 1997 Jun; 272(23):14592-9. PubMed ID: 9169418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1.
    Gill RK; Atkins LM; Hollis BW; Bell NH
    Mol Endocrinol; 1998 Jan; 12(1):57-65. PubMed ID: 9440810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor interacts with DnaK/heat shock protein 70: identification of DnaK interaction site on vitamin D receptor.
    Swamy N; Mohr SC; Xu W; Ray R
    Arch Biochem Biophys; 1999 Mar; 363(2):219-26. PubMed ID: 10068443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation.
    Sutton AL; Zhang X; Ellison TI; Macdonald PN
    Mol Endocrinol; 2005 Sep; 19(9):2234-44. PubMed ID: 15890672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
    Zella LA; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
    Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
    Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Lin NU; Malloy PJ; Sakati N; al-Ashwal A; Feldman D
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2564-9. PubMed ID: 8675579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
    Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
    Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.